If You Can't Be With The Stock You Love, Love The Stock Your With!! (ci)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CANB GlobeNewswire•July 9, 2018, DISTRIBUTION:
The Company's commitment to penetrate the medical community will and always has been the foundation of our growth. This decision has made a very positive impact to our Private Physician Affiliate Program. Our corporate sales to Functional and Alternative medical practices has grown. Our nationwide Roll-Out has begun and continues to grow dramatically due to our strong affiliation with very clear-cut distribution channels. We see exponential growth to Doctors and Medical Practices nationwide selling Canbiola products. We have developed a new section on our site to help our potential clients locate doctors and practices in their locality. This feature can be found through our website at https://canbiola.com/find-us-contact-us/.
$CANB GlobeNewswire•July 9, 2018, DISTRIBUTION:
The Company's commitment to penetrate the medical community will and always has been the foundation of our growth. This decision has made a very positive impact to our Private Physician Affiliate Program. Our corporate sales to Functional and Alternative medical practices has grown. Our nationwide Roll-Out has begun and continues to grow dramatically due to our strong affiliation with very clear-cut distribution channels. We see exponential growth to Doctors and Medical Practices nationwide selling Canbiola products. We have developed a new section on our site to help our potential clients locate doctors and practices in their locality. This feature can be found through our website at https://canbiola.com/find-us-contact-us/.
$CANB News! The LOI contemplates a process during which the two companies will hash out the precise details of a definitive agreement, whereby ISBG will draw upon its vast stores of knowledge and experience when it comes to taking a variety of ingredients and suppliers and producing a high-quality bottled beverage of complex composition with a branding advantage, and Canbiola will provide CBD in a form and through a process that integrates into that picture effectively.
Marco Alfonsi, Canbiola CEO, added, “The market for CBD and CBD related products is growing at an exceptional rate, fueled by consumers’ increasing awareness of the effects and benefits of CBD. Canbiola manufactures what I believe to be the finest proprietary CBD products on the market today, and I expect that quality to cross over to this new line of products. I look forward to this relationship and its vast potential.”
Additional details on the definitive agreement – once it is negotiated and entered between the parties – will follow.
About ISBG: ISBG is a Nevada-based alcoholic beverage company specializing in the development, marketing and global sales of innovative wine and spirits brands. The Company's expertise lies in the strategic development and aggressive early growth of its brands and establishing these brands as viable and profitable. ISBG intends to build its own brands while seeking out individual acquisition candidates to continue to develop its pipeline of new brands into the ISBG portfolio. For more information visit: www.isbg.global
Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with OTC Markets (www.otcmarkets.com).
$CANB News! The LOI contemplates a process during which the two companies will hash out the precise details of a definitive agreement, whereby ISBG will draw upon its vast stores of knowledge and experience when it comes to taking a variety of ingredients and suppliers and producing a high-quality bottled beverage of complex composition with a branding advantage, and Canbiola will provide CBD in a form and through a process that integrates into that picture effectively.
Marco Alfonsi, Canbiola CEO, added, “The market for CBD and CBD related products is growing at an exceptional rate, fueled by consumers’ increasing awareness of the effects and benefits of CBD. Canbiola manufactures what I believe to be the finest proprietary CBD products on the market today, and I expect that quality to cross over to this new line of products. I look forward to this relationship and its vast potential.”
Additional details on the definitive agreement – once it is negotiated and entered between the parties – will follow.
About ISBG: ISBG is a Nevada-based alcoholic beverage company specializing in the development, marketing and global sales of innovative wine and spirits brands. The Company's expertise lies in the strategic development and aggressive early growth of its brands and establishing these brands as viable and profitable. ISBG intends to build its own brands while seeking out individual acquisition candidates to continue to develop its pipeline of new brands into the ISBG portfolio. For more information visit: www.isbg.global
Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with OTC Markets (www.otcmarkets.com).
$CANB News! In line with a wave of recent strategic investments, the Company is convinced that the CBD-infused beverage market represents an enormous opportunity within the CBD and craft spirits twin booms.
“This has become the hottest new thing in terms of strategic investments,” commented ISBG CEO, Terry Williams. “Everyone is starting to see the same thing right now, and we deeply believe that a relationship between ISBG and Canbiola will allow us to set ourselves apart from our competitors.”
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB News! In line with a wave of recent strategic investments, the Company is convinced that the CBD-infused beverage market represents an enormous opportunity within the CBD and craft spirits twin booms.
“This has become the hottest new thing in terms of strategic investments,” commented ISBG CEO, Terry Williams. “Everyone is starting to see the same thing right now, and we deeply believe that a relationship between ISBG and Canbiola will allow us to set ourselves apart from our competitors.”
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB News! International Spirits and Beverage Group Inc. (ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits market, is excited to announce that it has signed a letter of intent (“LOI”) with Canbiola, Inc. (CANB) (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products, for CANB to provide hemp extracted CBD for inclusion in our new line of CBD-infused alcoholic and non-alcoholic beverages, as well as CBD Chews, for sale in North America.
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
Sorry about the double posts etc. PC went screwy 8(
$CANB News! International Spirits and Beverage Group Inc. (ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits market, is excited to announce that it has signed a letter of intent (“LOI”) with Canbiola, Inc. (CANB) (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products, for CANB to provide hemp extracted CBD for inclusion in our new line of CBD-infused alcoholic and non-alcoholic beverages, as well as CBD Chews, for sale in North America.
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB News! ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership.
GlobeNewswire•September 11, 2018
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB News! ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership.
GlobeNewswire•September 11, 2018
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB News! Canbiola, Inc. (OTC PINK: CANB) in its continuing effort to attract and partner with industry experts in the Global Health and Wellness field is proud to announced today that Dr. David J. Weissberg is joining the Medical Advisory Board and has also signed on as a Private Label customer.
Dr. Weissberg stated, “I’m very pleased to join the Medical Advisory team, to both collaborate on new products and explore the benefits of CBD for patients. To date, I have used this product on both myself and dozens of my patients and have been very satisfied with both the potent non-narcotic pain relief it affords my patients as well as the low risk of adverse side effects commonly seen in both traditional non-steroidal anti-inflammatory drugs and narcotic medications. CBD has very potent anti-inflammatory properties bringing down the swelling, stiffness, and warmth seen in arthritic joints and post-traumatic injuries. I believe that many physician specialties will find good indications for its use making it a very affordable and safe medication without the high risks associated with traditional prescription drugs. Additionally, Chiropractors who are unable to prescribe medications will be able to offer this over the counter medication for their patients who frequently suffer from both post-traumatic and neurologic injuries. The research and results thus far are very compelling and I’m excited for the prospects these products will offer for a variety of ailments. I will strive to help the Canbiola team put the best products possible on the market for both consumers and patients”.
Marco Alfonsi, Canbiola CEO, stated, “We are continuing to execute our plan to strengthen not only our Medical Advisory Board but also our distribution network. With the addition of Dr. Weissberg, we have added the 8th doctor to our Medical Advisory Board. I believe this addition will benefit our product development, to have true medical experts advise and offer input as we develop new products is an invaluable resource. Coupling the continued and increased acceptance of CBD with our development of new products for different uses will continue our growth and sales while expanding our client base. At Canbiola we are building an extraordinary team, and look to be an industry leader going forward. My enthusiasm for our future and the direction of the industry as a whole is very strong, I want to thank our team and shareholders for their support.”
Dr. Weissberg joins a growing all-star medical advisory team that already has the following members:
Dr. Maciej Matt Ferenc joins Canbiola as Medical Advisor and Distributor
Dr. Channing Coe joins Canbiola as Medical Advisor and Distributor
Dr. Robert A. Kornfeld Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. John P. Salerno Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Harry Benisatto joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Smita Ohri joins Canbiola as Medical Advisor and Distributor
About Dr. Weissberg:
Over 25 years in private practice, Dr. Weissberg has honed a meticulous and moderate approach to orthopedic care. A co-owner of the Melville Surgery Center and certified in the ImPACT™ Protocol – served as team physician for the Huntington, Walt Whitman, and Northport high school football teams, he is expert in the diagnosis and treatment of musculoskeletal injuries and conditions. He specializes in the arthroscopic treatment of shoulder, knee and ankle problems, including meniscal injuries, anterior cruciate ligament tears, labral and rotator tears, impingement syndromes, and instability issues.
Long Island Orthopedic Solutions (6 locations and 30,000+ patients)
Comprehensive, Conservative Treatment and Rehabilitation Options
That’s Long Island Orthopedic Solutions: minimal invasion with maximum results. The most advanced technological treatments and physical therapy combine to encourage the body’s natural healing abilities, providing quicker results while often avoiding traditional surgical options.
With over five decades of combined experience, our clinical staff is expert in time-tested medicines and therapies and the latest diagnosis and treatment protocols, including surgical and nonsurgical orthopedic solutions and ImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing) computerized evaluation tools and services.
$CANB News! Canbiola, Inc. (OTC PINK: CANB) in its continuing effort to attract and partner with industry experts in the Global Health and Wellness field is proud to announced today that Dr. David J. Weissberg is joining the Medical Advisory Board and has also signed on as a Private Label customer.
Dr. Weissberg stated, “I’m very pleased to join the Medical Advisory team, to both collaborate on new products and explore the benefits of CBD for patients. To date, I have used this product on both myself and dozens of my patients and have been very satisfied with both the potent non-narcotic pain relief it affords my patients as well as the low risk of adverse side effects commonly seen in both traditional non-steroidal anti-inflammatory drugs and narcotic medications. CBD has very potent anti-inflammatory properties bringing down the swelling, stiffness, and warmth seen in arthritic joints and post-traumatic injuries. I believe that many physician specialties will find good indications for its use making it a very affordable and safe medication without the high risks associated with traditional prescription drugs. Additionally, Chiropractors who are unable to prescribe medications will be able to offer this over the counter medication for their patients who frequently suffer from both post-traumatic and neurologic injuries. The research and results thus far are very compelling and I’m excited for the prospects these products will offer for a variety of ailments. I will strive to help the Canbiola team put the best products possible on the market for both consumers and patients”.
Marco Alfonsi, Canbiola CEO, stated, “We are continuing to execute our plan to strengthen not only our Medical Advisory Board but also our distribution network. With the addition of Dr. Weissberg, we have added the 8th doctor to our Medical Advisory Board. I believe this addition will benefit our product development, to have true medical experts advise and offer input as we develop new products is an invaluable resource. Coupling the continued and increased acceptance of CBD with our development of new products for different uses will continue our growth and sales while expanding our client base. At Canbiola we are building an extraordinary team, and look to be an industry leader going forward. My enthusiasm for our future and the direction of the industry as a whole is very strong, I want to thank our team and shareholders for their support.”
Dr. Weissberg joins a growing all-star medical advisory team that already has the following members:
Dr. Maciej Matt Ferenc joins Canbiola as Medical Advisor and Distributor
Dr. Channing Coe joins Canbiola as Medical Advisor and Distributor
Dr. Robert A. Kornfeld Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. John P. Salerno Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Harry Benisatto joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
Dr. Smita Ohri joins Canbiola as Medical Advisor and Distributor
About Dr. Weissberg:
Over 25 years in private practice, Dr. Weissberg has honed a meticulous and moderate approach to orthopedic care. A co-owner of the Melville Surgery Center and certified in the ImPACT™ Protocol – served as team physician for the Huntington, Walt Whitman, and Northport high school football teams, he is expert in the diagnosis and treatment of musculoskeletal injuries and conditions. He specializes in the arthroscopic treatment of shoulder, knee and ankle problems, including meniscal injuries, anterior cruciate ligament tears, labral and rotator tears, impingement syndromes, and instability issues.
Long Island Orthopedic Solutions (6 locations and 30,000+ patients)
Comprehensive, Conservative Treatment and Rehabilitation Options
That’s Long Island Orthopedic Solutions: minimal invasion with maximum results. The most advanced technological treatments and physical therapy combine to encourage the body’s natural healing abilities, providing quicker results while often avoiding traditional surgical options.
With over five decades of combined experience, our clinical staff is expert in time-tested medicines and therapies and the latest diagnosis and treatment protocols, including surgical and nonsurgical orthopedic solutions and ImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing) computerized evaluation tools and services.
$CANB Latest News. Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC GlobeNewswire•September 20, 2018
https://finance.yahoo.com/news/canbiola-inc-otc-pink-canb-142252693.html
Sizzling Company Profile $CANB
CANB - Canbiola, Inc.
According To the Canbiola Inc. Website
Sizzler Company Profile
Website http://www.canbiola.com/
Canbiola, Inc. is a US Company specializing in the sale of a variety of Cannabidiol (CBD) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is developing their own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and Legal Medical Marijuana Industry.
The CANB Mission:
Canbiola is committed to providing the highest quality and lowest cost hemp solutions with the highest purity standards in the industry.
Values:
Canbiola and it's employees are passionate about improving people's lives. We take pride in providing pure products infused with organic and natural ingredients. When purchasing our products, we want customers to know that they are buying lab tested, high quality natural products at a great price.
What Is Hemp Oil and Cannabidiol?
What is Cannabidiol ?
Sizzling Company Profile $CANB
CANB - Canbiola, Inc.
According To the Canbiola Inc. Website
Sizzler Company Profile
Website http://www.canbiola.com/
Canbiola, Inc. is a US Company specializing in the sale of a variety of Cannabidiol (CBD) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is developing their own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and Legal Medical Marijuana Industry.
The CANB Mission:
Canbiola is committed to providing the highest quality and lowest cost hemp solutions with the highest purity standards in the industry.
Values:
Canbiola and it's employees are passionate about improving people's lives. We take pride in providing pure products infused with organic and natural ingredients. When purchasing our products, we want customers to know that they are buying lab tested, high quality natural products at a great price.
What Is Hemp Oil and Cannabidiol?
What is Cannabidiol ?
Monday Sizzling Company Profile $CANB
CANB - Canbiola, Inc.
According To the Canbiola Inc. Website
Sizzler Company Profile
Website http://www.canbiola.com/
Canbiola, Inc. is a US Company specializing in the sale of a variety of Cannabidiol (CBD) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is developing their own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and Legal Medical Marijuana Industry.
The CANB Mission:
Canbiola is committed to providing the highest quality and lowest cost hemp solutions with the highest purity standards in the industry.
Values:
Canbiola and it's employees are passionate about improving people's lives. We take pride in providing pure products infused with organic and natural ingredients. When purchasing our products, we want customers to know that they are buying lab tested, high quality natural products at a great price.
What Is Hemp Oil and Cannabidiol?
What is Cannabidiol ?
Monday Sizzling Company Profile $CANB
CANB - Canbiola, Inc.
According To the Canbiola Inc. Website
Sizzler Company Profile
Website http://www.canbiola.com/
Canbiola, Inc. is a US Company specializing in the sale of a variety of Cannabidiol (CBD) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is developing their own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and Legal Medical Marijuana Industry.
The CANB Mission:
Canbiola is committed to providing the highest quality and lowest cost hemp solutions with the highest purity standards in the industry.
Values:
Canbiola and it's employees are passionate about improving people's lives. We take pride in providing pure products infused with organic and natural ingredients. When purchasing our products, we want customers to know that they are buying lab tested, high quality natural products at a great price.
What Is Hemp Oil and Cannabidiol?
What is Cannabidiol ?
$CANB CBD Facts
The plant genus Cannabis contains two unique plant species — hemp, a tall cane-like plant resembling bamboo that originated in Central Asia and is now cultivated worldwide; and marijuana, hemp’s shorter, leafier, cousin.
$CANB CBD Facts
The plant genus Cannabis contains two unique plant species — hemp, a tall cane-like plant resembling bamboo that originated in Central Asia and is now cultivated worldwide; and marijuana, hemp’s shorter, leafier, cousin.
$CANB What is Cannabidiol ?
The plant genus Cannabis contains two unique plant species — hemp, a tall cane-like plant resembling bamboo that originated in Central Asia and is now cultivated worldwide; and marijuana, hemp’s shorter, leafier, cousin.
Cannabis naturally produces more than 80 chemical compounds, called cannabinoids. The two most common, and therefore most studied, are tetrahydrocannabinol (referred to as THC) and cannabidoil (or the simpler term, CBD.) THC is the compound responsible for psychoactive effects. CBD is non-psychoactive, meaning it doesn’t cause a “high.” In very general terms, cannabis plants with high THC content are considered marijuana; while plants with less than 1% THC are considered hemp.
CBD is what we’ll be discussing here today. There’s no standard amount in hemp or marijuana, so they may have high or low amounts. CBD is fully legal in the United States as long as it comes from imported industrial hemp seeds and stalks. Industrial hemp is typically grown for its fibers, seeds and other parts, which are used to make thousands of products. When hemp oil is extracted from these plants, they can have a surprising amount of CBD.
Many stores now carry products that contain CBD oil. But, these are considered food or supplements. They’re intended to support overall health and wellness.
CBD has been studied all over the world by renowned scientists and universities. These pre-clinical studies are suggesting CBD’s potential for reducing a number of different symptoms such as anxiety, nausea and inflammation, among others. These studies are still underway and the FDA does not allow claims to be made about the effectiveness of CBD for any particular health concern.
Based on anecdotes, a common response to CBD is an overall feeling of calmness and relaxation. Although plenty of other narratives can be seen in the news, and some states have already legalized the use of domestically grown CBD oil to reduce seizures or other ailments — more clinical studies are needed to influence a change in federal laws.
$CANB What is Cannabidiol ?
The plant genus Cannabis contains two unique plant species — hemp, a tall cane-like plant resembling bamboo that originated in Central Asia and is now cultivated worldwide; and marijuana, hemp’s shorter, leafier, cousin.
Cannabis naturally produces more than 80 chemical compounds, called cannabinoids. The two most common, and therefore most studied, are tetrahydrocannabinol (referred to as THC) and cannabidoil (or the simpler term, CBD.) THC is the compound responsible for psychoactive effects. CBD is non-psychoactive, meaning it doesn’t cause a “high.” In very general terms, cannabis plants with high THC content are considered marijuana; while plants with less than 1% THC are considered hemp.
CBD is what we’ll be discussing here today. There’s no standard amount in hemp or marijuana, so they may have high or low amounts. CBD is fully legal in the United States as long as it comes from imported industrial hemp seeds and stalks. Industrial hemp is typically grown for its fibers, seeds and other parts, which are used to make thousands of products. When hemp oil is extracted from these plants, they can have a surprising amount of CBD.
Many stores now carry products that contain CBD oil. But, these are considered food or supplements. They’re intended to support overall health and wellness.
CBD has been studied all over the world by renowned scientists and universities. These pre-clinical studies are suggesting CBD’s potential for reducing a number of different symptoms such as anxiety, nausea and inflammation, among others. These studies are still underway and the FDA does not allow claims to be made about the effectiveness of CBD for any particular health concern.
Based on anecdotes, a common response to CBD is an overall feeling of calmness and relaxation. Although plenty of other narratives can be seen in the news, and some states have already legalized the use of domestically grown CBD oil to reduce seizures or other ailments — more clinical studies are needed to influence a change in federal laws.
$CANB What Is CBD Video. The Inside Story of Cannabidiol
$CANB What Is CBD Video. The Inside Story of Cannabidiol
$CANB NEWS! 9/20/18 Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC
GlobeNewswire • September 20, 2018
Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC
https://finance.yahoo.com/news/canbiola-inc-otc-pink-canb-142252693.html
$CANB NEWS! 9/20/18 Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC
GlobeNewswire • September 20, 2018
Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC
https://finance.yahoo.com/news/canbiola-inc-otc-pink-canb-142252693.html
$CANB Latest News About ISBG
About ISBG: ISBG is a Nevada-based alcoholic beverage company specializing in the development, marketing and global sales of innovative wine and spirits brands. The Company's expertise lies in the strategic development and aggressive early growth of its brands and establishing these brands as viable and profitable. ISBG intends to build its own brands while seeking out individual acquisition candidates to continue to develop its pipeline of new brands into the ISBG portfolio. For more information visit: www.isbg.global
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News About ISBG
About ISBG: ISBG is a Nevada-based alcoholic beverage company specializing in the development, marketing and global sales of innovative wine and spirits brands. The Company's expertise lies in the strategic development and aggressive early growth of its brands and establishing these brands as viable and profitable. ISBG intends to build its own brands while seeking out individual acquisition candidates to continue to develop its pipeline of new brands into the ISBG portfolio. For more information visit: www.isbg.global
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News Marco Alfonsi, Canbiola CEO, added, “The market for CBD and CBD related products is growing at an exceptional rate, fueled by consumers’ increasing awareness of the effects and benefits of CBD. Canbiola manufactures what I believe to be the finest proprietary CBD products on the market today, and I expect that quality to cross over to this new line of products. I look forward to this relationship and its vast potential.”
Additional details on the definitive agreement – once it is negotiated and entered between the parties – will follow.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News Marco Alfonsi, Canbiola CEO, added, “The market for CBD and CBD related products is growing at an exceptional rate, fueled by consumers’ increasing awareness of the effects and benefits of CBD. Canbiola manufactures what I believe to be the finest proprietary CBD products on the market today, and I expect that quality to cross over to this new line of products. I look forward to this relationship and its vast potential.”
Additional details on the definitive agreement – once it is negotiated and entered between the parties – will follow.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News The LOI contemplates a process during which the two companies will hash out the precise details of a definitive agreement, whereby ISBG will draw upon its vast stores of knowledge and experience when it comes to taking a variety of ingredients and suppliers and producing a high-quality bottled beverage of complex composition with a branding advantage, and Canbiola will provide CBD in a form and through a process that integrates into that picture effectively.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News The LOI contemplates a process during which the two companies will hash out the precise details of a definitive agreement, whereby ISBG will draw upon its vast stores of knowledge and experience when it comes to taking a variety of ingredients and suppliers and producing a high-quality bottled beverage of complex composition with a branding advantage, and Canbiola will provide CBD in a form and through a process that integrates into that picture effectively.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News In line with a wave of recent strategic investments, the Company is convinced that the CBD-infused beverage market represents an enormous opportunity within the CBD and craft spirits twin booms.
“This has become the hottest new thing in terms of strategic investments,” commented ISBG CEO, Terry Williams. “Everyone is starting to see the same thing right now, and we deeply believe that a relationship between ISBG and Canbiola will allow us to set ourselves apart from our competitors.”
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News In line with a wave of recent strategic investments, the Company is convinced that the CBD-infused beverage market represents an enormous opportunity within the CBD and craft spirits twin booms.
“This has become the hottest new thing in terms of strategic investments,” commented ISBG CEO, Terry Williams. “Everyone is starting to see the same thing right now, and we deeply believe that a relationship between ISBG and Canbiola will allow us to set ourselves apart from our competitors.”
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News! GlobeNewswire • September 11, 2018
- International Spirits and Beverage Group Inc. (ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits market, is excited to announce that it has signed a letter of intent (“LOI”) with Canbiola, Inc. (CANB) (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products, for CANB to provide hemp extracted CBD for inclusion in our new line of CBD-infused alcoholic and non-alcoholic beverages, as well as CBD Chews, for sale in North America.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News! GlobeNewswire • September 11, 2018
- International Spirits and Beverage Group Inc. (ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits market, is excited to announce that it has signed a letter of intent (“LOI”) with Canbiola, Inc. (CANB) (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products, for CANB to provide hemp extracted CBD for inclusion in our new line of CBD-infused alcoholic and non-alcoholic beverages, as well as CBD Chews, for sale in North America.
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News! ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB Latest News! ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
GlobeNewswire • September 11, 2018
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
https://finance.yahoo.com/news/isbg-signs-letter-intent-canbiola-120000320.html
$CANB CBD has been studied all over the world by renowned scientists and universities. These pre-clinical studies are suggesting CBD’s potential for reducing a number of different symptoms such as anxiety, nausea and inflammation, among others. These studies are still underway and the FDA does not allow claims to be made about the effectiveness of CBD for any particular health concern.
$CANB CBD has been studied all over the world by renowned scientists and universities. These pre-clinical studies are suggesting CBD’s potential for reducing a number of different symptoms such as anxiety, nausea and inflammation, among others. These studies are still underway and the FDA does not allow claims to be made about the effectiveness of CBD for any particular health concern.